Old Web
English
Sign In
Acemap
>
Paper
>
25665 Efficacy and safety of mirikizumab in psoriasis: 52-week results from the OASIS-1 randomized controlled trial
25665 Efficacy and safety of mirikizumab in psoriasis: 52-week results from the OASIS-1 randomized controlled trial
2021
Andrew Blauvelt
Alexa B. Kimball
Matthias Augustin
Yukari Okubo
Michael Witte
Claudia Rodríguez Capriles
Angelina Sontag
Vipin Arora
Olawale Osuntokun
Bruce E. Strober
Keywords:
Psoriasis
Randomized controlled trial
Internal medicine
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]